Download PDF
Horm Metab Res 2021; 53(09): 594-601
DOI: 10.1055/a-1518-7503
Endocrine Care

Triglyceride-Glucose Index Predicts Adverse Events in Patients with Acute Coronary Syndrome: A Meta-Analysis of Cohort Studies

Juying Li
1   Department of Cardiovascular Medicine, The First People’s Hospital of Yibin City, Yibin, China
,
Ling Ren
1   Department of Cardiovascular Medicine, The First People’s Hospital of Yibin City, Yibin, China
,
Cheng Chang
1   Department of Cardiovascular Medicine, The First People’s Hospital of Yibin City, Yibin, China
,
Lin Luo
1   Department of Cardiovascular Medicine, The First People’s Hospital of Yibin City, Yibin, China
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Correction to:

Correction: Triglyceride-Glucose Index Predicts Adverse Events in Patients with Acute Coronary Syndrome: A Meta-Analysis of Cohort StudiesHorm Metab Res 2021; 53(09): e3-e3
DOI: 10.1055/a-1651-8774

Abstract

The triglyceride-glucose (TyG) index, a recently proposed indicator for insulin resistance, has been related with cardiovascular risks. We aimed to summarize the association between TyG index and incidence of major adverse cardiovascular events (MACEs) in patients with acute coronary syndrome (ACS). Cohort studies demonstrating the association between TyG index and incidence of MACEs in ACS patients with multivariate adjusted analyses were identified by search of PubMed, Embase, and Web of Science databases. A random-effekt model incorporating the heterogeneity was applied to pool the results. Eight cohort studies with 19 611 participants were included. Results showed that compared to those with the lowest category of TyG index, ACS patients with the highest category of TyG index were independently associated with higher risk of MACEs [risk ratio (RR): 1.94, 95% confidence interval (CI): 1.47–2.56, I2=85%, p <0.001). Subgroup analyses showed consistent results in patients with ST-segment elevated myocardial infarction or non-ST segment elevated ACS, in patients with or without diabetes, and in patients after percutaneous coronary intervention. Results were consistent in studies with TyG index analyzed as continuous variable (RR for per standard deviation increment of TyG index: 1.59, 95% CI: 1.38–1.83, I2=24%, p <0.001). In conclusion, higher TyG index may be independently associated with higher incidence of MACEs in patients with ACS.

Key words

triglyceride-glucose index - insulin resistance - acute coronary syndrome - major adverse cardiovascular events - meta-analysis


Publication History

Received: 16 March 2021

Accepted after revision: 12 May 2021

Article published online:
23 July 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Jia S, Liu Y, Yuan J. Evidence in Guidelines for Treatment of Coronary Artery Disease. Adv Exp Med Biol 2020; 1177: 37-73
    CrossrefPubMedGoogle Scholar
  • 2 Daghash H, Lim Abdullah K, Ismail MD. The effekt of acute coronary syndrome care pathways on in-hospital patients: A systematic review. J Eval Clin Pract 2020; 26: 1280-1291
    CrossrefPubMedGoogle Scholar
  • 3 Virani SS, Alonso A, Aparicio HJ. et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021 CIR0000000000000950
    Google Scholar
  • 4 Neumann FJ, Sousa-Uva M, Ahlsson A. et al. 2018; ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019: 87-165
    PubMedGoogle Scholar
  • 5 Aarts GWA, Mol JQ, Camaro C. et al. Recent developments in diagnosis and risk stratification of non-ST-elevation acute coronary syndrome. Neth Heart J 2020; 28: 88-92
    CrossrefPubMedGoogle Scholar
  • 6 Chan Pin Yin D, Azzahhafi J, James S. Risk Assessment Using Risk Scores in Patients with Acute Coronary Syndrome. J Clin Med. 2020 9. 3039 DOI: 10.3390/jcm9093039.
    Google Scholar
  • 7 Adeva-Andany MM, Martinez-Rodriguez J, Gonzalez-Lucan M. et al. Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metab Syndr 2019; 13: 1449-1455
    CrossrefPubMedGoogle Scholar
  • 8 Patel TP, Rawal K, Bagchi AK. et al. Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes. Heart Fail Rev 2016; 21: 11-23
    CrossrefPubMedGoogle Scholar
  • 9 Gerstein HC, Ferrannini E, Riddle MC. et al. Insulin resistance and cardiovascular outcomes in the ORIGIN trial. Diabetes Obes Metab 2018; 20: 564-570
    CrossrefPubMedGoogle Scholar
  • 10 Rebelos E, Honka MJ. PREDIM index: a useful tool for the application of the euglycemic hyperinsulinemic clamp. J Endocrinol Invest 2021; 44: 631-634
    CrossrefPubMedGoogle Scholar
  • 11 Tura A, Chemello G, Szendroedi J. et al. Prediction of clamp-derived insulin sensitivity from the oral glucose insulin sensitivity index. Diabetologia 2018; 61: 1135-1141
    CrossrefPubMedGoogle Scholar
  • 12 Alizargar J, Bai CH, Hsieh NC. et al. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol 2020; 19: 8
    CrossrefPubMedGoogle Scholar
  • 13 Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med 2020; 18: 361
    CrossrefPubMedGoogle Scholar
  • 14 da Silva A, Caldas APS, Hermsdorff HHM. et al. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol 2019; 18: 89
    CrossrefPubMedGoogle Scholar
  • 15 Won KB, Park EJ, Han D. et al. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol 2020; 19: 34
    CrossrefPubMedGoogle Scholar
  • 16 Park K, Ahn CW, Lee SB. et al. Elevated TyG Index Predicts Progression of Coronary Artery Calcification. Diabetes Care 2019; 42: 1569-1573
    CrossrefPubMedGoogle Scholar
  • 17 Luo E, Wang D, Yan G. et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol 2019; 18: 150
    CrossrefPubMedGoogle Scholar
  • 18 Mao Q, Zhou D, Li Y. et al. The Triglyceride-Glukose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. Dis Markers 2019; 6891537
    PubMedGoogle Scholar
  • 19 Hu C, Zhang J, Liu J. et al. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: A cohort study from China. Cardiovasc Diabetol 2020; 19: 116
    CrossrefPubMedGoogle Scholar
  • 20 Ma X, Dong L, Shao Q. et al. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovasc Diabetol 2020; 19: 31
    CrossrefPubMedGoogle Scholar
  • 21 Wang L, Cong HL, Zhang JX. et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol 2020; 19: 80
    CrossrefPubMedGoogle Scholar
  • 22 Zhang Y, Ding X, Hua B. et al. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Nutr Metab Cardiovasc Dis 2020; 30: 2351-2362
    CrossrefPubMedGoogle Scholar
  • 23 Zhao Q, Zhang TY, Cheng YJ. et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol 2020; 19: 108
    CrossrefPubMedGoogle Scholar
  • 24 Zhao Q, Zhang TY, Cheng YJ. et al. Triglyceride-Glukose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. J Atheroscler Thromb. 2020 DOI: 10.5551/jat.59840. Online ahead of print
    Google Scholar
  • 25 Stroup DF, Berlin JA, Morton SC. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012
    CrossrefPubMedGoogle Scholar
  • 26 Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. 2011 www.cochranehandbook.org
    Google Scholar
  • 27 Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 2008; 6: 299-304
    CrossrefPubMedGoogle Scholar
  • 28 Wells GA, Shea B, O'Connell D. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2010 http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
    Google Scholar
  • 29 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558
    CrossrefPubMedGoogle Scholar
  • 30 Patsopoulos NA, Evangelou E, Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 2008; 37: 1148-1157
    CrossrefPubMedGoogle Scholar
  • 31 Egger M, Davey Smith G, Schneider M. et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
    CrossrefPubMedGoogle Scholar
  • 32 Won KB, Kim YS, Lee BK. et al. The relationship of insulin resistance estimated by triglyceride glucose index and coronary plaque characteristics. Medicine (Baltimore) 2018; 97: e10726
    CrossrefPubMedGoogle Scholar
  • 33 Matulewicz N, Karczewska-Kupczewska M. Insulin resistance and chronic inflammation. Postepy Hig Med Dosw (Online) 2016; 70: 1245-1258
    PubMedGoogle Scholar
  • 34 Bentzon JF, Otsuka F, Virmani R. et al. Mechanisms of plaque formation and rupture. Circ Res 2014; 114: 1852-1866
    CrossrefPubMedGoogle Scholar
  • 35 Ormazabal V, Nair S, Elfeky O. et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol 2018; 17: 122
    CrossrefPubMedGoogle Scholar
  • 36 Poon AK, Whitsel EA, Heiss G. et al. Insulin resistance and reduced cardiac autonomic function in older adults: the Atherosclerosis Risk in Communities study. BMC Cardiovasc Disord 2020; 20: 217
    CrossrefPubMedGoogle Scholar
  • 37 Cieslik-Guerra UI, Fila M, Kaminski M. et al. Correlation between the activity of the autonomic nervous system and endothelial function in patients with acute coronary syndrome. Pol Arch Med Wewn 2014; 124: 509-515
    PubMedGoogle Scholar
  • 38 Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M. et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 2010; 95: 3347-3351
    CrossrefPubMedGoogle Scholar
  • 39 Vasques AC, Novaes FS, de Oliveira Mda S. et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 2011; 93: e98-e100
    CrossrefPubMedGoogle Scholar
  • 40 Shahavandi M, Djafari F, Shahinfar H. et al. The association of plant-based dietary patterns with visceral adiposity, lipid accumulation product, and triglyceride-glucose index in Iranian adults. Complement Ther Med 2020; 53: 102531
    CrossrefPubMedGoogle Scholar